Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Ferrati

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 9, 2015
Functional validation of an implantable medical dosing device by MRI at 3TJeff R Anderson, Silvia Ferrati, Chistof Karmonik, et al.
International Journal of Pharmaceutics|July 28, 2018
Dosing considerations for inhaled biologicsSilvia Ferrati, Tian Wu, Sekhar R Kanapuram, et al.
Molecular Pharmaceutics|October 20, 2017
Excipient-Free Pulmonary Delivery and Macrophage Targeting of Clofazimine via Air Jet MicronizationAshlee D Brunaugh, Syed Umer Jan, Silvia Ferrati, et al.
Current Drug Targets|February 24, 2015
Docetaxel/2-Hydroxypropyl β -Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery SystemSilvia Ferrati, Eugenia Nicolov, Shyam Bansal, et al.
Nanoscale|July 21, 2010
Mitotic trafficking of silicon microparticlesRita E Serda, Silvia Ferrati, Biana Godin, et al.
Current Pharmaceutical Design|February 11, 2016
Inhaled Biologics: From Preclinical to Product ApprovalKristin Fathe, Silvia Ferrati, Daniel Moraga-Espinoza, et al.
Journal of Pharmaceutical Sciences|April 27, 2018
Development, Characterization, and In Vitro Testing of Co-Delivered Antimicrobial Dry Powder Formulation for the Treatment of Pseudomonas aeruginosa BiofilmsTania F Bahamondez-Canas, Silvia Ferrati, Daniel F Moraga-Espinoza, et al.
Current Drug Targets|June 1, 2013
Validated RP-HPLC method for the simultaneous analysis of gemcitabine and LY-364947 in liposomal formulationsShyam S Bansal, Christian Celia, Silvia Ferrati, et al.
Chemical Communications (Cambridge, England)|March 29, 2007
A new organogelator based on an enantiopure C2 symmetric pyrrolidineStefano Cicchi, Giacomo Ghini, Luisa Lascialfari, et al.
AAPS Pharmscitech|March 1, 2018
Influence of Formulation Factors on the Aerosol Performance and Stability of Lysozyme Powders: a Systematic ApproachSilvia Ferrati, Tian Wu, Omar Fuentes, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 9, 2015
Functional validation of an implantable medical dosing device by MRI at 3TJeff R Anderson, Silvia Ferrati, Chistof Karmonik, et al.
International Journal of Pharmaceutics|July 28, 2018
Dosing considerations for inhaled biologicsSilvia Ferrati, Tian Wu, Sekhar R Kanapuram, et al.
Molecular Pharmaceutics|October 20, 2017
Excipient-Free Pulmonary Delivery and Macrophage Targeting of Clofazimine via Air Jet MicronizationAshlee D Brunaugh, Syed Umer Jan, Silvia Ferrati, et al.
Current Drug Targets|February 24, 2015
Docetaxel/2-Hydroxypropyl β -Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery SystemSilvia Ferrati, Eugenia Nicolov, Shyam Bansal, et al.
Nanoscale|July 21, 2010
Mitotic trafficking of silicon microparticlesRita E Serda, Silvia Ferrati, Biana Godin, et al.
Current Pharmaceutical Design|February 11, 2016
Inhaled Biologics: From Preclinical to Product ApprovalKristin Fathe, Silvia Ferrati, Daniel Moraga-Espinoza, et al.
Journal of Pharmaceutical Sciences|April 27, 2018
Development, Characterization, and In Vitro Testing of Co-Delivered Antimicrobial Dry Powder Formulation for the Treatment of Pseudomonas aeruginosa BiofilmsTania F Bahamondez-Canas, Silvia Ferrati, Daniel F Moraga-Espinoza, et al.
Current Drug Targets|June 1, 2013
Validated RP-HPLC method for the simultaneous analysis of gemcitabine and LY-364947 in liposomal formulationsShyam S Bansal, Christian Celia, Silvia Ferrati, et al.
Chemical Communications (Cambridge, England)|March 29, 2007
A new organogelator based on an enantiopure C2 symmetric pyrrolidineStefano Cicchi, Giacomo Ghini, Luisa Lascialfari, et al.
AAPS Pharmscitech|March 1, 2018
Influence of Formulation Factors on the Aerosol Performance and Stability of Lysozyme Powders: a Systematic ApproachSilvia Ferrati, Tian Wu, Omar Fuentes, et al.
Pageof 3